ArticleJournal of experimental & clinical cancer research : CR2021

Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer.

Pietro Paolo Vitiello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.